Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chitogenx Inc C.CHGX

Alternate Symbol(s):  CHNXF

ChitogenX Inc. is a Canada-based emerging orthopedic and sports medicine biologics company. The Company is engaged in the development of therapeutic soft tissue repair technologies to improve the success rate of orthopedic and sports medicine surgeries. The Company’s proprietary biopolymer has been specifically designed to increase the healing rates of occupational and sports related injuries... see more

Recent & Breaking News (CSE:CHGX)

CHITOGENX SUCCESSFULLY COMPLETES INITIAL PORTION OF ITS U.S. PHASE I/II ROTATOR CUFF REPAIR CLINICAL TRIAL

Canada NewsWire November 9, 2022

CHITOGENX SIGNS MEMORANDUM OF UNDERSTANDING WITH CALIFORNIA MEDICAL INNOVATIONS INSTITUTE (CALMI²)

Canada NewsWire October 19, 2022

CHITOGENX LAUNCHES SECOND ORTHOPEDIC DEVELOPMENT PROGRAM IN MENISCUS REPAIR

Canada NewsWire October 13, 2022

CHITOGENX TO PURSUE SALES OF MEDICAL GRADE CHITOSAN AS NEW NEAR-TERM REVENUE INITIATIVE

Canada NewsWire October 5, 2022

CHITOGENX REPORTS ITS SECOND QUARTER 2023 RESULTS

Canada NewsWire September 29, 2022

CSE Bulletin: Name and Symbol Change - Ortho Regenerative Technologies Inc. (ORTH)

Newsfile September 7, 2022

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX

PR Newswire September 7, 2022

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

PR Newswire July 27, 2022

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

Canada NewsWire July 22, 2022

ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTS

Canada NewsWire June 24, 2022

ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

PR Newswire June 13, 2022

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR

PR Newswire May 26, 2022

ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTS

Canada NewsWire May 20, 2022

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM

PR Newswire May 4, 2022

ORTHO REGENERATIVE TECHNOLOGIES CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT FOR $3.2 MILLION

Canada NewsWire April 6, 2022

ORTHO REGENERATIVE TECHNOLOGIES TO PARTICIPATE IN THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC AND HOSTED BY M-VEST

PR Newswire March 24, 2022

ORTHO REGENERATIVE TECHNOLOGIES AMENDS THE TERMS OF ITS $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS

Canada NewsWire March 21, 2022

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

PR Newswire March 15, 2022

Ortho Regenerative Technologies (CSE:ORTH) announces $3M private placement

John Ballem  March 3, 2022

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS

PR Newswire February 11, 2022